Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Dyslipidaemia Drug Market to grow at a CAGR of 3.5 percent during the forecast period

(Medical-NewsWire.com, September 04, 2023 ) The “Dyslipidaemia Drug Market” was valued USD 13.58 Bn in 2022 and is expected to grow at a CAGR of 3.5 percent over the forecast period to reach USD 17.76 Bn by 2029.



Dyslipidaemia Drug Market Scope and Research Methodology



The objective of the report is to present a comprehensive analysis of the Dyslipidaemia Drug Market. SWOT analysis was done to find strengths and weaknesses in the market. The market is segmented based on Drug Class, Distribution Channel, and Age Group.



Purchase Report : https://www.maximizemarketresearch.com/request-sample/209378



Dyslipidaemia Drug Market Dynamics



Increased cardiovascular disease and high spending on research and development activities is expected to boost the Dyslipidaemia Drug Market growth. The high cost of drugs is expected to restrain the market growth.



Dyslipidaemia Drug Market Regional Insight



North America is expected to boost the Dyslipidaemia Drug market growth over the forecast period. An increasing number of patients suffering from dyslipidaemia is expected to boost the Dyslipidaemia Drug industry growth.



Purchase Report : https://www.maximizemarketresearch.com/request-sample/209378



Dyslipidaemia Drug Market Segmentation



By Drug Class:



Statin

Bile Acid Sequestrants

Fibrates

Nicotinic Acid



By Distribution Channel:



Hospital Pharmacy

Retail Pharmacy

Online



By Age Group:



Paediatric

Adult

Geriatric



Purchase Report : https://www.maximizemarketresearch.com/request-sample/209378



Dyslipidaemia Drug Market Key Players Include



Pfizer Inc. - USA

Merck & Co., Inc. – USA

Bristol Myers Squibb (BMS) - USA

Regeneron Pharmaceuticals, Inc. - USA

Mylan N.V. - USA

Amgen Inc. - USA

Eli Lilly and Company - USA

AbbVie Inc. - USA

GlaxoSmithKline plc - United Kingdom

AstraZeneca - United Kingdom/Sweden

Novartis International AG - Switzerland

Sanofi - France

Boehringer Ingelheim - Germany

Teva Pharmaceutical Industries Ltd. - Israel

Sun Pharmaceutical Industries Ltd. - India

Lupin Limited - India



Maximize Market Research is leading Information Biotechnology research firm, has also published the following reports:



Lifestyle Drugs Market: The market size is expected to reach USD 163.52 Bn by 2029 at a CAGR of 7.1 percent during the forecast period.



Dystonia Drugs Market: The total market size is expected to reach USD 15.1 Mn by 2029 at a CAGR of 6.8 percent over the forecast period.



About Maximize Market Research:



Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

MAXIMIZE MARKET RESEARCH PVT. LTD.

Dnyaneshwari Yevale

09607365656

akash.r@maximizemarketresearch.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC